Accession Number:

ADA413097

Title:

Novel Concepts for Soldier-centric Technology in Non-Traditional Combat Casualty Care. Development of a Decontamination System for BW Agents for Military and Civilian Use: Decon of Soldier Wounds, Personnel, and Materiel

Descriptive Note:

Final rept. Nov 2002-May 2003

Corporate Author:

STERIFX INC SHREVEPORT LA

Personal Author(s):

Report Date:

2003-04-11

Pagination or Media Count:

25.0

Abstract:

SteriFx, Inc has demonstrated feasibility that our technology can provide an answer to the problem of biological decontamination based upon the properties of our new aqueous compound, CleanseFx. This proprietary compound is the basis for the development and commercialization of a line of antimicrobial and wound care products, even to include a cold sterilant. The compound is an aqueous acidic mixture with a pH of less than 1, normally considered toxic or dangerous, however the method of manufacture and final composition of the compound results in a solution that is acidic while retaining a large margin of safety. The low pH of the solution provides for an environment that destroys bacteria on living skin within minutes, without harming the host. This efficacy coupled with safety could provide a system for personnel and civilian decon. A military training mission demonstrating use was carried out, and indications are that CleanseFx was preferred over standard hypochlorite solutions that harm skin, eyes, clothes, as the hypochlorite label specifically prohibits use on human tissues. CleanseFx is currently marketed as an FDA-cosmetic product.

Subject Categories:

  • Medicine and Medical Research
  • Radiobiology
  • Microbiology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE